ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.650,03
-1,38%
S&P 500
5.307,01
-0,27%
US Dollar vs BRL
5,1527
0,00%
Bitcoin
69.512,96
0,59%
Brent Oil
81,17
-0,44%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aadi Bioscience Inc (AADI)

  7. Aadi Bioscience Inc (AADI) Notícias

AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AADI
DataHoraFonteTítuloCódigoCompanhia
08/05/202417:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AADIAadi Bioscience Inc
08/05/202409:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
08/05/202409:00PR Newswire (US)Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
01/05/202409:01PR Newswire (US)Aadi Bioscience to Report First Quarter 2024 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
09/04/202409:00PR Newswire (US)Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
17/03/202409:00PR Newswire (US)Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)NASDAQ:AADIAadi Bioscience Inc
13/03/202409:00PR Newswire (US)Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
06/03/202410:00PR Newswire (US)Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
05/03/202418:30PR Newswire (US)Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:AADIAadi Bioscience Inc
04/03/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
01/03/202418:08PR Newswire (US)Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComaNASDAQ:AADIAadi Bioscience Inc
01/03/202415:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
26/02/202418:05PR Newswire (US)Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
12/02/202419:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AADIAadi Bioscience Inc
12/02/202419:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AADIAadi Bioscience Inc
26/01/202418:05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers SymposiumNASDAQ:AADIAadi Bioscience Inc
19/01/202418:05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers SymposiumNASDAQ:AADIAadi Bioscience Inc
14/12/202318:05PR Newswire (US)Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating AlterationsNASDAQ:AADIAadi Bioscience Inc
08/11/202318:28Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AADIAadi Bioscience Inc
08/11/202310:00PR Newswire (US)Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
06/11/202318:05PR Newswire (US)Aadi Bioscience to Participate in Jefferies London Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
01/11/202317:05PR Newswire (US)Aadi Bioscience to Report Third Quarter 2023 Results and Operational UpdateNASDAQ:AADIAadi Bioscience Inc
19/10/202317:05PR Newswire (US)Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global MeetingNASDAQ:AADIAadi Bioscience Inc
12/10/202317:05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:AADIAadi Bioscience Inc
05/10/202317:05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical SymposiumNASDAQ:AADIAadi Bioscience Inc
03/10/202319:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
03/10/202317:05PR Newswire (US)Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)NASDAQ:AADIAadi Bioscience Inc
02/10/202309:00PR Newswire (US)Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive OfficerNASDAQ:AADIAadi Bioscience Inc
05/09/202309:00PR Newswire (US)Aadi Bioscience to Participate at Upcoming Investor ConferencesNASDAQ:AADIAadi Bioscience Inc
09/08/202309:00PR Newswire (US)Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AADI

Seu Histórico Recente

ASX
GSIQ30
Australian Government Tr...
NASDAQ
AHI
Advanced Health Intellig...
DGFX
LOVEUSDT
Love
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados